Literature DB >> 9665185

Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis.

J Roy1, C Ryckman, V Bernier, R Whittom, R Delage.   

Abstract

Persistent polyclonal B cell lymphocytosis (PPBL) is a rare lymphoproliferative disorder of unclear natural history and its potential for B cell malignancy remains unknown. We describe the case of a 39-year-old female who presented with stage IV-B large cell lymphoma 19 years after an initial diagnosis of PPBL; her disease was rapidly fatal despite intensive chemotherapy and blood stem cell transplantation. Because we had recently identified multiple bcl-2/Ig gene rearrangements in blood mononuclear cells of patients with PPBL, we sought evidence of this oncogene in this particular patient: bcl-2/Ig gene rearrangements were found in blood mononuclear cells but not in lymphoma cells. Owing to the possible role of Epstein-Barr virus (EBV) in the pathogenesis of PPBL, we also hypothesized our patient might have an EBV-related lymphoproliferative disorder. Despite serologies consistent with past exposure to this virus, it was not found in lymphoma cells using a sensitive polymerase chain reaction technique. We conclude that non-Hodgkin's lymphoma may occur during the course of PPBL. However, longer follow-up in more patients will be needed in order to better clarity the risk of hematologic malignancy in patients with PPBL.

Entities:  

Mesh:

Year:  1998        PMID: 9665185     DOI: 10.1038/sj.leu.2401040

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Authors:  E Cornet; J F Lesesve; H Mossafa; G Sébahoun; V Levy; F Davi; X Troussard
Journal:  Leukemia       Date:  2008-07-31       Impact factor: 11.528

2.  B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Authors:  Nadine Voelxen; Claudia Wehr; Sylvia Gutenberger; Baerbel Keller; Miriam Erlacher; Cecilia Dominguez-Conde; Daniela Bertele; Florian Emmerich; Milena Pantic; Stefanie Jennings; Mirzokhid Rakhmanov; Christian Foerster; Uwe M Martens; Uwe Platzbecker; Hans-Hartmut Peter; Paul Fisch; Kaan Boztug; Hermann Eibel; Ulrich Salzer; Klaus Warnatz
Journal:  Immunol Cell Biol       Date:  2016-04-29       Impact factor: 5.126

3.  [Asymptomatic 32 year old female smoker with persistent polyclonal lymphocytosis].

Authors:  B Chapuy; G Wulf; H W Tessen; F Griesinger; L Trümper; R Schroers
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

4.  Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL).

Authors:  Xavier Troussard; Edouard Cornet; Jean-François Lesesve; Carine Kourel; Hossein Mossafa
Journal:  Onco Targets Ther       Date:  2008-10-01       Impact factor: 4.147

5.  Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction.

Authors:  Emmanuelle Dugas-Bourdages; Sonia Néron; Annie Roy; André Darveau; Robert Delage
Journal:  Adv Hematol       Date:  2014-12-14

6.  Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification.

Authors:  Edouard Cornet; Hossein Mossafa; Karine Courel; Jean-François Lesesve; Xavier Troussard
Journal:  BMC Res Notes       Date:  2016-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.